论文部分内容阅读
目的了解慢性收缩性心力衰竭治疗建议(简称心衰治疗建议)临床应用现状与效果。方法对比分析心衰治疗建议公布前后(2002年度前为A组,后为B组)10年间住院的慢性心力衰竭(CHF)患者临床资料、药物治疗和预后的差异。结果①共收治患者620例,其中A组178例,B组442例,两组患者的一般临床情况、NYHA心功能分级和超声心动图有关指标比较差异无统计学意义(P>0.05);②B组患者血管紧张素转换酶抑制剂、β-受体阻滞剂和螺内酯的使用率明显高于A组,地高辛和利尿剂使用率低于A组;③A组患者平均住院天数(14.26±15.08)显著长于B组(10.83±6.93),差异有统计学意义(P=0.005)。④A组患者住院期间死亡(4/178例)明显高于B组(1/422例)。结论心衰治疗建议规范了凉州医院CHF治疗,缩短了住院时间,降低了住院死亡人数。
Objective To understand the clinical application and treatment of chronic systolic heart failure (short for heart failure treatment recommendations). Methods The clinical data, drug treatment and prognosis of patients with chronic heart failure (CHF) hospitalized 10 years before and after the recommendation of heart failure treatment (group A before 2002 and group B afterwards) were compared and analyzed. Results ① A total of 620 patients were treated, including 178 cases in group A and 442 cases in group B. There was no significant difference between the two groups in general clinical features, NYHA classification and echocardiography (P> 0.05); ②B Group A patients with angiotensin converting enzyme inhibitors, β-blockers and spironolactone use rate was significantly higher than that of group A, digoxin and diuretic use rate was lower than that of group A; ③A group of patients with an average length of stay (14.26 ± 15.08) was significantly longer than the B group (10.83 ± 6.93), the difference was statistically significant (P = 0.005). ④A group of patients died during hospitalization (4/178 cases) was significantly higher than the B group (1/422 cases). Conclusions The recommendations of heart failure treatment regulates CHF treatment in Liangzhou Hospital, shortening the hospitalization time and reducing the number of hospitalized deaths.